AVA vs Mira — how do they compare? AVA trades at Rp3,196 (market cap Rp236,56M, Rp158,09M 24h volume), while Mira trades at Rp700.16 (market cap Rp224,01M, Rp102,95M 24h volume). The key difference: AVA and Mira are close in size by market cap, and AVA's circulating supply is 74,4M / 100M AVA (75%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold AVA for 24 Days and Mira for 22 Days on average.
| AVA | MIRA | |
|---|---|---|
Market Cap | Rp236,56M | Rp224,01M |
Volume (24h) | Rp158,09M | Rp102,95M |
Circulating Supply | 74,4M / 100M AVA (75%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 24 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
AVA is trading at Rp3,211.22 with a market cap of Rp239.34 million, showing a bearish technical signal overall. The asset faces resistance near Rp3,317 and support at Rp3,153, with neutral oscillators but bearish moving averages. On-chain metrics indicate 74.4 million tokens in circulation (75% of max supply) and an average hold time of 24 days. Recent crypto-specific news highlights Travala's focus on AI travel infrastructure (Benzinga, 2026-06-15), suggesting ecosystem development.
Outlook is cautious due to bearish technicals and limited liquidity. Key opportunities include AI integration growth, but risks involve low market cap volatility and regulatory uncertainty. Investors should monitor trading volume and network adoption for signs of stability.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
The AVA token, created by the AVA Foundation, enhances customer loyalty programs using blockchain technology. It powers the AVA Smart Program, a Web3 loyalty system offering rewards, discounts, and exclusive benefits. AVA can also be used for payments on partner platforms and for community governance.
Read more on AVA →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →